The North America Sclerotherapy Market would witness market growth of 7.2% CAGR during the forecast period (2020-2026). Sclerotherapy is a type of minimally invasive procedure that are used for the treatment of or varicose veins. This involves injecting sclerosing agents such as detergents, chemicals, and osmotic agents in the vein. Sclerosing agent cause shrinking of the veins thereby reduces the damage and remove appearance of them. The growing patient geriatric population, technological advancements pertaining to venous diseases, increasing incidence of varicose veins, and rising demand minimally invasive procedures are some of the factors that are driving the market. The introduction of foam sclerotherapy, and ultrasound-guided sclerotherapy has allowed practitioners to adopt these procedures for the painful and underlying veins with accuracy and care. Primary varicose veins are a medical condition in which the congestion occurs in the superficial venous system and may result into eczema and stasis dermatitis.
The attention of both doctors and patients has been shifted towards less-invasive treatment procedures, availability of advanced treatment devices for varicose vein, as well as huge burden of varicose vein cases are the main driving factors in the growth of the market. Other factors include improvement in patient reliability and compliance, increasing healthcare expenditure, and swift growth in aging population.
Though, lack of training for vascular surgeons, expensive treatment procedures for varicose vein, and healthcare reforms in the U.S. and other developed countries are some of the main factors limiting the growth of market. In addition, many challenges are associated with unreliable reimbursement scenario for the varicose vein treatment procedures in the highly competitive market limits the growth of the market.
Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Sclerotherapy Market in North America is expected to register a CAGR of 7.2% during the forecast period (2020-2026)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.
Scope of the North America Sclerotherapy Market Analysis
Market Segmentation:
By Agent
- Detergents
- Osmotic Agents
- Chemical Irritants
By Type
- Liquid Sclerotherapy
- Ultrasound Sclerotherapy
- Foam Sclerotherapy
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Boston Scientific Corporation
- Perrigo Company PLC (Omega Pharmaceuticals)
- Cook Medical, Inc. (Cook Group)
- Chemische Fabrik Kreussler & Co. GmbH
- LGM Pharma, LLC
- Troikaa Pharmaceuticals Limited
- Tianyu Chang’an Group
- Endo-Flex GmbH (Meditek Systems)
- Merz Pharma GmbH & Co. KGaA
- MTW-Endoskopie W. Haag KG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sclerotherapy Market, by Agent
1.4.2 North America Sclerotherapy Market, by Type
1.4.3 North America Sclerotherapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Sclerotherapy Market by Agent
3.1 North America Detergents Market by Country
3.2 North America Osmotic Agents Market by Country
3.3 North America Chemical Irritants Market by Country
Chapter 4. North America Sclerotherapy Market by Type
4.1 North America Liquid Sclerotherapy Market by Country
4.2 North America Ultrasound Sclerotherapy Market by Country
4.3 North America Other Type Market by Country
Chapter 5. North America Sclerotherapy Market by Country
5.1 US Sclerotherapy Market
5.1.1 US Sclerotherapy Market by Agent
5.1.2 US Sclerotherapy Market by Type
5.2 Canada Sclerotherapy Market
5.2.1 Canada Sclerotherapy Market by Agent
5.2.2 Canada Sclerotherapy Market by Type
5.3 Mexico Sclerotherapy Market
5.3.1 Mexico Sclerotherapy Market by Agent
5.3.2 Mexico Sclerotherapy Market by Type
5.4 Rest of North America Sclerotherapy Market
5.4.1 Rest of North America Sclerotherapy Market by Agent
5.4.2 Rest of North America Sclerotherapy Market by Type
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
TABLE 1 North America Sclerotherapy Market, 2016 - 2019, USD Million
TABLE 2 North America Sclerotherapy Market, 2020 - 2026, USD Million
TABLE 3 North America Sclerotherapy Market by Agent, 2016 - 2019, USD Million
TABLE 4 North America Sclerotherapy Market by Agent, 2020 - 2026, USD Million
TABLE 5 North America Detergents Market by Country, 2016 - 2019, USD Million
TABLE 6 North America Detergents Market by Country, 2020 - 2026, USD Million
TABLE 7 North America Osmotic Agents Market by Country, 2016 - 2019, USD Million
TABLE 8 North America Osmotic Agents Market by Country, 2020 - 2026, USD Million
TABLE 9 North America Chemical Irritants Market by Country, 2016 - 2019, USD Million
TABLE 10 North America Chemical Irritants Market by Country, 2020 - 2026, USD Million
TABLE 11 North America Sclerotherapy Market by Type, 2016 - 2019, USD Million
TABLE 12 North America Sclerotherapy Market by Type, 2020 - 2026, USD Million
TABLE 13 North America Liquid Sclerotherapy Market by Country, 2016 - 2019, USD Million
TABLE 14 North America Liquid Sclerotherapy Market by Country, 2020 - 2026, USD Million
TABLE 15 North America Ultrasound Sclerotherapy Market by Country, 2016 - 2019, USD Million
TABLE 16 North America Ultrasound Sclerotherapy Market by Country, 2020 - 2026, USD Million
TABLE 17 North America Other Type Market by Country, 2016 - 2019, USD Million
TABLE 18 North America Other Type Market by Country, 2020 - 2026, USD Million
TABLE 19 North America Sclerotherapy Market by Country, 2016 - 2019, USD Million
TABLE 20 North America Sclerotherapy Market by Country, 2020 - 2026, USD Million
TABLE 21 US Sclerotherapy Market, 2016 - 2019, USD Million
TABLE 22 US Sclerotherapy Market, 2020 - 2026, USD Million
TABLE 23 US Sclerotherapy Market by Agent, 2016 - 2019, USD Million
TABLE 24 US Sclerotherapy Market by Agent, 2020 - 2026, USD Million
TABLE 25 US Sclerotherapy Market by Type, 2016 - 2019, USD Million
TABLE 26 US Sclerotherapy Market by Type, 2020 - 2026, USD Million
TABLE 27 Canada Sclerotherapy Market, 2016 - 2019, USD Million
TABLE 28 Canada Sclerotherapy Market, 2020 - 2026, USD Million
TABLE 29 Canada Sclerotherapy Market by Agent, 2016 - 2019, USD Million
TABLE 30 Canada Sclerotherapy Market by Agent, 2020 - 2026, USD Million
TABLE 31 Canada Sclerotherapy Market by Type, 2016 - 2019, USD Million
TABLE 32 Canada Sclerotherapy Market by Type, 2020 - 2026, USD Million
TABLE 33 Mexico Sclerotherapy Market, 2016 - 2019, USD Million
TABLE 34 Mexico Sclerotherapy Market, 2020 - 2026, USD Million
TABLE 35 Mexico Sclerotherapy Market by Agent, 2016 - 2019, USD Million
TABLE 36 Mexico Sclerotherapy Market by Agent, 2020 - 2026, USD Million
TABLE 37 Mexico Sclerotherapy Market by Type, 2016 - 2019, USD Million
TABLE 38 Mexico Sclerotherapy Market by Type, 2020 - 2026, USD Million
TABLE 39 Rest of North America Sclerotherapy Market, 2016 - 2019, USD Million
TABLE 40 Rest of North America Sclerotherapy Market, 2020 - 2026, USD Million
TABLE 41 Rest of North America Sclerotherapy Market by Agent, 2016 - 2019, USD Million
TABLE 42 Rest of North America Sclerotherapy Market by Agent, 2020 - 2026, USD Million
TABLE 43 Rest of North America Sclerotherapy Market by Type, 2016 - 2019, USD Million
TABLE 44 Rest of North America Sclerotherapy Market by Type, 2020 - 2026, USD Million
TABLE 45 key Information – Boston Scientific Corporation
TABLE 46 Key Information – Perrigo Company PLC
TABLE 47 key Information – Cook Medical, Inc.
TABLE 48 Key information – Chemische Fabrik Kreussler & Co. GmbH
TABLE 49 Key Information – LGM Pharma, LLC
TABLE 50 key Information – Troikaa Pharmaceuticals Limited
TABLE 51 key Information – Tianyu Chang’an Group
TABLE 52 Key Information –Endo-Flex GmbH
TABLE 53 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 54 Key Information – MTW-Endoskopie W. Haag KG
List of Figures
FIG 1 Methodology for the research